OZANIMOD HYDROCHLORIDE | N209899 | BRISTOL MYERS SQUIBB CO
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2024-07-02 | Terminated 2025-09-15 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Kaylin Bower FDA-2026-P-0775 · 2 docket documents Kaylin Bower filed this citizen petition with the FDA on January 24, 2026, requesting that the agency correct or remove misleading statements in FDA approval tables for multiple sclerosis drugs including Kesimpta, Aubagio, Ponvory, Gilenya, Mayzent, and Zeposia that present relative risk reductions | Other | 2026-01-27 | Open | Kaylin Bower |
Source: Regulations.gov. FDA citizen petitions matched by application number.